Inventor · disambiguated record
Robert T. Peters
Also filed as: PETERS ROBERT · PETERS ROBERT T · PETERS ROBERT THOMAS
57 granted patents·48 pending applications·1,445 citations·filing 2004–2025
99Inventor score
Files withBIOVERATIV THERAPEUTICS INC64SYNTONIX PHARMACEUTICALS INC8BIOGEN MA INC7AMUNIX OPERATING INC3BIOGEN HEMOPHILIA INC3
Top patents by PatentIndex Score
105 records- 0199US7381408B2Methods for chemically synthesizing immunoglobulin chimeric proteinsSYNTONIX PHARMACEUTICALS INC·Filed 2004·Granted Jun 3, 2008·173 cites·26 claims
- 0298US9867873B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2015·Granted Jan 16, 2018·17 cites·25 claims
- 0398US9675676B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2016·Granted Jun 13, 2017·19 cites·30 claims
- 0498US9629903B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2016·Granted Apr 25, 2017·17 cites·29 claims
- 0598US9623091B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2016·Granted Apr 18, 2017·16 cites·28 claims
- 0698US7862820B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2006·Granted Jan 4, 2011·120 cites·13 claims
- 0798US7404956B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2004·Granted Jul 29, 2008·301 cites·48 claims
- 0898US7348004B2Immunoglobulin chimeric monomer-dimer hybridsSYNTONIX PHARMACEUTICALS INC·Filed 2005·Granted Mar 25, 2008·218 cites·20 claims
- 0997US10898554B1Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2020·Granted Jan 26, 2021·6 cites·22 claims
- 1097US7566565B2PC5 as a factor IX propeptide processing enzymeSYNTONIX PHARMACEUTICALS INC·Filed 2007·Granted Jul 28, 2009·44 cites·22 claims
- 1196US10568943B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Feb 25, 2020·6 cites·18 claims
- 1296US9233145B2Factor IX polypeptides and methods of use thereofBIOGEN HEMOPHILIA INC·Filed 2013·Granted Jan 12, 2016·27 cites·22 claims
- 1396US8449884B2Clotting factor-fc chimeric proteins to treat hemophiliaRIVERA DANIEL S·Filed 2010·Granted May 28, 2013·65 cites·24 claims
- 1496US8329182B2Immunoglobulin chimeric monomer-dimer hybridsPETERS ROBERT T·Filed 2010·Granted Dec 11, 2012·82 cites·38 claims
- 1596US7820162B2Methods for chemically synthesizing immunoglobulin chimeric proteinsSYNTONIX PHARMACEUTICALS INC·Filed 2008·Granted Oct 26, 2010·26 cites·16 claims
- 1695US10548954B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Feb 4, 2020·5 cites·16 claims
- 1795US9636416B2Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2014·Granted May 2, 2017·20 cites·22 claims
- 1894US11266720B2Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Mar 8, 2022·6 cites·64 claims
- 1994US10138291B2Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Nov 27, 2018·30 cites·36 claims
- 2094US9670475B2Factor IX polypeptides and methods of use thereofPIERCE GLENN·Filed 2011·Granted Jun 6, 2017·18 cites·34 claims
- 2194US8932830B2Immunoglobulin chimeric monomer-dimer hybridsBIOGEN IDEC HEMOPHILIA INC·Filed 2012·Granted Jan 13, 2015·25 cites·27 claims
- 2294US8021880B2PC5 as a factor IX propeptide processing enzymeSYNTONIX PHARMACEUTICALS INC·Filed 2010·Granted Sep 20, 2011·17 cites·23 claims
- 2393US11192936B2Factor VIII chimeric proteins and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2015·Granted Dec 7, 2021·10 cites·58 claims
- 2493US11091534B2Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Aug 17, 2021·8 cites·20 claims
- 2593US10881742B2Factor VIII chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Jan 5, 2021·5 cites·26 claims
- 2693US10561714B2Factor IX polypeptides and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2018·Granted Feb 18, 2020·3 cites·20 claims
- 2793US9050318B2Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereofDUMONT JENNIFER A·Filed 2010·Granted Jun 9, 2015·28 cites·31 claims
- 2893US8815250B2Clotting factor-Fc chimeric proteins to treat hemophiliaBIOGEN IDEC HEMOPHILIA INC·Filed 2013·Granted Aug 26, 2014·19 cites·24 claims
- 2992US7795400B2PC5 as a factor IX propeptide processing enzymeSYNTONIX PHARMACEUTICALS INC·Filed 2009·Granted Sep 14, 2010·10 cites·15 claims
- 3091US10421798B2Factor VIII compositions and methods of making and using sameSCHELLENBERGER VOLKER·Filed 2012·Granted Sep 24, 2019·16 cites·44 claims
- 3191US10370431B2Optimized factor VIII geneBIOVERATIV THERAPEUTICS INC·Filed 2014·Granted Aug 6, 2019·6 cites·16 claims
- 3290US11008561B2Optimized factor IX geneBIOVERATIV THERAPEUTICS INC·Filed 2015·Granted May 18, 2021·4 cites·22 claims
- 3390US9725496B1Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2017·Granted Aug 8, 2017·4 cites·27 claims
- 3490US9241978B2Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereofBIOGEN HEMOPHILIA INC·Filed 2013·Granted Jan 26, 2016·15 cites·21 claims
- 3589US10745680B2Factor IX fusion proteins and methods of making and using sameBIOVERATIV THERAPEUTICS INC·Filed 2016·Granted Aug 18, 2020·6 cites·27 claims
- 3689US10548953B2Factor VIII-XTEN fusions and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2014·Granted Feb 4, 2020·6 cites·17 claims
- 3788US12186375B2Factor VIII chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2020·Granted Jan 7, 2025·1 cites·19 claims
- 3888US11370827B2Chimeric factor VIII polypeptides and uses thereofBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted Jun 28, 2022·5 cites·48 claims
- 3988US11225650B2Methods of using FIX polypeptidesBIOVERATIV THERAPEUTICS INC·Filed 2017·Granted Jan 18, 2022·5 cites·20 claims
- 4087US11168125B2Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Nov 9, 2021·1 cites·10 claims
- 4186US12275970B2Optimized factor IX geneBIOVERATIV THERAPEUTICS INC·Filed 2020·Granted Apr 15, 2025·1 cites·15 claims
- 4286US2025195620A1Factor viii chimeric and hybrid polypeptides, and methods of use thereofBIOVERATIV THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4384US10010622B2Factor VIII chimeric and hybrid polypeptides, and methods of use thereofDUMONT JENNIFER A·Filed 2012·Granted Jul 3, 2018·7 cites·22 claims
- 4484US2023023927A1Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4583US11787851B2Optimized factor VIII geneBIOVERATIV THERAPEUTICS INC·Filed 2019·Granted Oct 17, 2023·1 cites·12 claims
- 4682US9611310B2Systems for factor VIII processing and methods thereofLOW SUSAN C·Filed 2011·Granted Apr 4, 2017·4 cites·25 claims
- 4782US2022010000A1Immunoglobulin chimeric monomer-dimer hybridsBIOVERATIV THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4881US10927362B2Processable single chain molecules and polypeptides made using sameBIOVERATIV THERAPEUTICS INC·Filed 2017·Granted Feb 23, 2021·1 cites·14 claims
- 4981US10364288B2Anti-GPIIB/IIIA antibodies or uses thereofBIOGEN MA INC·Filed 2014·Granted Jul 30, 2019·3 cites·8 claims
- 5081US10287564B2Procoagulant compoundsBIOVERATIV THERAPEUTICS INC·Filed 2013·Granted May 14, 2019·5 cites·11 claims
Showing the top 50 of 105 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robert T. Peters files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →